Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-202 for periumbilical subcutaneous fat
NCT01802723Phase 2Completed
- Sponsor
- Neothetics
- Start
- Feb 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of salmeterol in subcutaneous fat, localized adiposity (AL), sponsored by Neothetics. Started Feb 2013; status: completed.
02
Drugs
salmeterol
03
Conditions
subcutaneous fatlocalized adiposity (AL)
Beyond the preview
Go deeper on NCT01802723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01802723.